LiDCO Group (LID) Receives Corporate Rating from FinnCap
FinnCap reiterated their corporate rating on shares of LiDCO Group (LON:LID) in a report published on Wednesday, ThisIsMoney.Co.Uk reports.
Shares of LiDCO Group stock opened at GBX 4.60 ($0.06) on Wednesday. The company has a market capitalization of $11.23 million and a price-to-earnings ratio of -5.75. LiDCO Group has a 52 week low of GBX 3.29 ($0.04) and a 52 week high of GBX 8.25 ($0.11).
In related news, insider Phil Cooper purchased 100,000 shares of the company’s stock in a transaction on Tuesday, March 26th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £4,000 ($5,226.71). Insiders acquired 1,000,000 shares of company stock worth $4,900,000 over the last quarter.
LiDCO Group Plc develops, manufactures, and sells hemodynamic monitoring equipment in the United Kingdom, the United States, Continental Europe, and internationally. The company provides a range of closed and open pressure monitoring sets for use in the ICU, operating department, and Cath labs; and Stimpod NMS 450X, a quantitative neuromuscular blocking agent monitor.
Featured Story: FAANG Stocks
Receive News & Ratings for LiDCO Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiDCO Group and related companies with MarketBeat.com's FREE daily email newsletter.